Natures Sunshine Products Bolsa (NASDAQ: NATR)

Natures Sunshine Products (NASDAQ:NATR) Bolsa

Natures Sunshine Products

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

ALTG

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CARM

CNCK

CRGX

FBNC

MGOL

NAOV

NATR

OFIX

RNGR

SLXN

TSLA

VREX

XFOR

Meta sube en la preapertura tras superar expectativas. Descubre qué otras acciones están registrando fuertes movimientos hoy.

Acciones de Meta Platforms (META) están cotizando al alza; 20 acciones que se mueven en el premercado de EE.UU.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NUKK

TMCI

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Advanced Environmental Recycling Technologies

AERT

AILE

CTXR

HONE

HSON

INTZ

KORE

LITM

PDYN

REKR

SLDP

VINC

WATT

Descubre los mayores ganadores y perdedores en el mercado previo tras movimientos impactantes en acciones clave hoy.

Las acciones de Vincerx Pharma (VINC) suben alrededor del 64%; 20 acciones que se mueven en premercado

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products Inc

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) affirms FY2025 sales outlook from $445.00 million-$470.00 million to $445.00 million-$470.00 million vs $460.02 million estimate.

Guidance

Natures Sunshine Products Affirms FY2025 Sales Guidance of $445.00M-$470.00M vs $460.02M Est

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.17 by 47.06 percent. This is a 108.33 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $113.25 million which beat the analyst consensus estimate of $109.39 million by 3.53 percent. This is a 2.03 percent increase over sales of $110.99 million the same period last year.

Earnings

Earnings Beats

Natures Sunshine Products Q1 Adj. EPS $0.25 Beats $0.17 Estimate, Sales $113.25M Beat $109.39M Estimate

ACLS

AHCO

ALAB

ALGS

ALGT

AMTM

ANDE

ANET

ANGI

ARDT

ARIS

ARMK

ARQT

ARRY

ATKR

ATOM

ATRO

AUDC

AVNS

AVNT

AVNW

AZEK

BALL

BBNX

BCAB

BLDP

BRLT

BWIN

BWMN

CCCS

CCLD

CDRE

CELH

CGAU

CGBD

CHMI

CHRD

CIFR

CIGI

CLDT

CLOV

COTY

CPAY

CPIX

CPNG

CRCT

CRIS

CRMD

CRSR

CRUS

CURI

CVGI

CXDO

CYTK

DASH

DAWN

DDOG

DOCN

DRCT

DRVN

DVAX

ENLT

EOSE

Embraer-Empresa Brasileira De Aeronautica

ESPR

EVGO

Earnings Scheduled For May 6, 2025

Management

Nature's Sunshine Appoints Heidi Wissmiller As Chairman of the Board, Effective April 30, 2025

Nature's Sunshine Expects 2025 Net Sales Of $445M - $470M, Est $457.32M

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.20 by 99.5 percent. This is a 99.78 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $118.20 million which beat the analyst consensus estimate of $109.48 million by 7.97 percent. This is a 8.51 percent increase over sales of $108.94 million the same period last year.

Earnings Misses

Natures Sunshine Products Q4 2024 Adj EPS $0.00 Misses $0.20 Estimate, Sales $118.20M Beat $109.48M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Exagen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XGN#NASDAQ">XGN</a>) is projected to report quarterly loss at $0.24 per share on revenue of $13.85 million. 
• Core Molding Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMT#AMEX">CMT</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $58.79 million. 
• FuelCell Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) is expected to report quarterly loss at $1.35 per share on revenue of $33.49 million. 
• BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $10.89 million. 
• Holley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLLY#NYSE">HLLY</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $137.60 million. 
• RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is expected to report quarterly loss at $0.23 per share on revenue of $278.42 million. 
• Bioventus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) is estimated to report quarterly earnings at $0.08 per share on revenue of $145.16 million. 
• Gauzy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAUZ#NASDAQ">GAUZ</a>) is estimated to report quarterly loss at $0.21 per share on revenue of $30.33 million. 
• Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) is expected to report quarterly loss at $2.54 per share on revenue of $30.09 million. 
• Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $5.18 billion. 
• First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $263.07 million. 
• United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $7.96 billion. 
• ECARX Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECX#NASDAQ">ECX</a>) is likely to report quarterly loss at $0.10 per share on revenue of $240.78 million. 
• Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $1.05 billion. 
• Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is likely to report quarterly earnings at $3.51 per share on revenue of $3.77 billion. 
• Endeavour Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) is projected to report quarterly loss at $0.01 per share on revenue of $47.78 million. 
• Endeavor Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>) is likely to report quarterly loss at $0.01 per share on revenue of $47.78 million. 
• European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $52.17 million. 
• QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $98.59 million. 
• Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $248.09 million. 
• ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $662.40 million. 
• Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) is expected to report quarterly loss at $0.33 per share on revenue of $178.93 million. 
• Ferguson Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) is expected to report quarterly earnings at $1.60 per share on revenue of $6.76 billion. 
• Achieve Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) is expected to report earnings for its fourth quarter. 
• 36KR Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRKR#NASDAQ">KRKR</a>) is expected to report earnings for its Fiscal Year 2024. 
• Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) is projected to report quarterly loss at $0.07 per share on revenue of $2.01 million. 
• Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is expected to report quarterly earnings at $1.13 per share on revenue of $650.45 million. 
• Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $13.40 million. 
• Ultralife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULBI#NASDAQ">ULBI</a>) is expected to report quarterly earnings at $0.15 per share on revenue of $40.00 million. 
• Viking Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) is expected to report quarterly earnings at $0.34 per share on revenue of $1.34 billion. 
• Wheels Up Experience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) is estimated to report earnings for its fourth quarter. 
• Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) is expected to report quarterly earnings at $0.78 per share on revenue of $114.00 million. 
• Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is estimated to report quarterly loss at $0.43 per share on revenue of $2.50 million. 
<h3>Companies Reporting After The Bell</h3>
• Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is projected to report quarterly loss at $0.01 per share on revenue of $12.93 million. 
• Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) is expected to report quarterly loss at $0.11 per share on revenue of $5.13 million. 
• Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $127.74 million. 
• SuRo Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSSS#NASDAQ">SSSS</a>) is likely to report quarterly loss at $0.21 per share on revenue of $492 thousand. 
• Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $17.20 million. 
• SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) is likely to report earnings for its fourth quarter. 
• Voyager Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) is expected to report quarterly loss at $0.35 per share on revenue of $16.58 million. 
• Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $53.65 million. 
• Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $1.30 million. 
• Superior Gr of Cos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGC#NASDAQ">SGC</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $146.54 million. 
• E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) is expected to report quarterly earnings at $0.99 per share on revenue of $716.06 million. 
• Cadre Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDRE#NYSE">CDRE</a>) is expected to report quarterly earnings at $0.51 per share on revenue of $171.77 million. 
• Zevra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVRA#NASDAQ">ZVRA</a>) is projected to report quarterly loss at $0.40 per share on revenue of $8.93 million. 
• Pursuit Attractions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRSU#NYSE">PRSU</a>) is estimated to report earnings for its fourth quarter. 
• Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) is projected to report quarterly loss at $0.15 per share on revenue of $48.79 million. 
• Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $43.76 million. 
• Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) is expected to report quarterly earnings at $0.20 per share on revenue of $109.46 million. 
• Finance of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOA#NYSE">FOA</a>) is likely to report quarterly earnings at $0.46 per share on revenue of $80.61 million. 
• Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $89.86 million. 
• loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) is likely to report quarterly loss at $0.01 per share on revenue of $310.08 million. 
• CuriosityStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $13.10 million. 
• Stitch Fix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) is projected to report quarterly loss at $0.11 per share on revenue of $297.27 million. 
• Eastern (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EML#NASDAQ">EML</a>) is likely to report earnings for its fourth quarter. 
• Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) is estimated to report quarterly loss at $3.45 per share on revenue of $55.86 million. 
• Westrock Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) is expected to report quarterly loss at $0.12 per share on revenue of $228.75 million. 
• Casey's General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) is likely to report quarterly earnings at $2.59 per share on revenue of $3.78 billion. 
• Oil-Dri Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ODC#NYSE">ODC</a>) is projected to report earnings for its second quarter. 
• Vitesse Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) is estimated to report quarterly earnings at $0.24 per share on revenue of $65.19 million. 
• Bowman Consulting Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWMN#NASDAQ">BWMN</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $110.71 million. 
• MaxCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $7.67 million. 
• Heritage Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>) is likely to report quarterly earnings at $0.58 per share on revenue of $208.37 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHV

AGEN

BBCP

BIRD

BWAY

CASY

CIEN

CSBR

ELTK

EWCZ

FCEL

FERG

FWRG

GAUZ

GBLI

GROV

GRPN

HLLY

HRTG

KRKR

LEGN

MXCT

NUWE

PRSU

RERE

RMBL

SFIX

SIGA

SMSI

SNCR

SSSS

SYRA

ULBI

UNFI

VRCA

VYGR

WEST

ZVRA

ZYXI

Earnings Scheduled For March 11, 2025

Shares of Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/general/social-media/25/01/43322201/meta-platforms-q4-earnings-revenue-beat-eps-beat-daily-actives-up-5-continued-strong-revenue-growth-expected">fourth-quarter sales results</a>.
Meta reported fourth-quarter revenue of $48.39 billion, beating analyst estimates of $47.03 billion. The company reported fourth-quarter earnings of $8.02 per share, beating analyst estimates of $6.77 per share.
Meta shares gained 2.2% to $691.66 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) gained 105% to $6.13 in pre-market trading.</li>
<li>NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) rose 54.1% to $0.5853 in pre-market trading.</li>
<li>X4 Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) gained 40.1% to $1.03 in pre-market trading after jumping more than 52% on Wednesday.</li>
<li>MGO Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) gained 21.9% to $0.1240 in pre-market trading after dipping over 38% on Wednesday.</li>
<li>Carisma Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) gained 18.4% to $0.5980 in pre-market trading.</li>
<li>Alta Equipment Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) rose 14.1% to $8.01 in pre-market trading.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares jumped 13.1% to $113.66 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Ranger Energy Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) gained 10.5% to $19.00 in pre-market trading.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 2.9% to $400.23 in pre-market trading. Tesla reported weaker-than-expected fourth-quarter earnings and sales results. The company, meanwhile, said it expects its vehicle business to return to growth in 2025. Tesla also promised to launch new and &#8220;more affordable&#8221; models in the first half of 2025, in addition to other promises regarding the deployment of autonomous vehicles and licensing of the company&#8217;s full self-driving (FSD) driver assistance software to rivals.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CARGO Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) shares fell 74.3% to $3.39 in pre-market trading after the company announced it discontinued its FIRCE-1 Phase 2 study.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) dipped 46.6% to $8.00 in pre-market trading.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares fell 32.4% to $2.12 in pre-market trading. Silexion Therapeutics announced exercise of warrants for $3.3 million gross proceeds.</li>
<li>Avalon Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWX#NYSE">AWX</a>) fell 19.2% to $2.90 in today's pre-market trading.</li>
<li>Coincheck Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNCK#NASDAQ">CNCK</a>) shares dipped 17.1% to $7.00 in pre-market trading after falling 4% on Wednesday.</li>
<li>Varex Imaging Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) shares tumbled 12.2% to $11.94 in pre-market trading. Varex Imaging will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, Feb. 6.</li>
<li>Whirlpool Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) fell 10.6% to $116.00 in pre-market trading after the company reported worse-than-expected fourth-quarter revenue results and issued FY25 guidance below estimates.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) fell 9.4% to $1,035.79 in pre-market trading after the company reported worse-than-expected quarterly revenue results.</li>
<li>Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) declined 9.1% to $17.01 in pre-market trading. Orthofix Medical will release its fourth quarter and full-year 2024 financial results on Tuesday, Feb. 25, before the opening bell.</li>
<li>First Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBNC#NASDAQ">FBNC</a>) fell 6.8% to $41.00 in pre-market trading following fourth-quarter earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43300989/jim-cramer-this-industrial-stock-is-absolutely-terrific-first-solar-is-very-inexpensive">Jim Cramer: This Industrial Stock Is &#8216;Absolutely Terrific&#8217;, First Solar Is &#8216;Very Inexpensive&#8217;</a></li>
</ul>

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>) rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strategy to grow its <a href="https://www.benzinga.com/quote/VS/news">international footprint</a>.
Versus Systems shares jumped 71.2% to $3.39 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) gained 49.1% to $4.25 in pre-market trading after the company announced it secured a supplier for hMPV biospecimens.</li>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) rose 33% to $27.30 in pre-market trading after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) rose 19.2% to $2.55 in pre-market trading after declining 9% on Thursday.</li>
<li>uCloudlink Group Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) gained 18.7% to $1.59 in pre-market trading. uCloudlink Group announced that it recently signed a cooperation agreement with WH Smith PLC&#8217;s InMotion Entertainment Group.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 15.3% to $0.2471 in pre-market trading after gaining around 7% on Thursday.</li>
<li>TXNM Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) gained 14.3% to $55.99 in pre-market trading.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) gained 14% to $9.40 in pre-market trading. On Monday, Treace announced preliminary, unaudited fourth quarter and full-year 2024 revenue.</li>
<li>LSI Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) rose 8.8% to $21.00 in pre-market trading. LSI Industries will issue fiscal 2025 second quarter results before the opening bell on Thursday, Jan. 23, 2025.</li>
<li>Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) gained 8.1% to $19.39 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Beasley Broadcast Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) fell 43.8% to $5.00 in pre-market trading.</li>
<li>Viavi Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) shares fell 19.3% to $8.10 in pre-market trading. Viavi Solutions will announce its fiscal second quarter 2025 financial results on Thursday, Jan. 30, 2025, after the close of market.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) fell 18.4% to $0.2566 in pre-market trading after gaining 58% on Thursday.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) shares dipped 15.9% to $12.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares tumbled 12.8% to $5.61 in pre-market trading.</li>
<li>G. Willi-Food International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WILC#NASDAQ">WILC</a>) shares fell 11.5% to $14.01 in pre-market trading.</li>
<li>Bicara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>) fell 11.5% to $10.51 in today's pre-market trading after declining 8% on Thursday.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) declined 10.3% to $167.00 in pre-market trading as the company reported weaker-than-expected earnings for its fourth quarter on Thursday.</li>
<li>MiMedx Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) dipped 6.3% to $8.50 in pre-market trading.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) fell 5% to $12.60 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43049593/slb-jb-hunt-transport-and-3-stocks-to-watch-heading-into-friday">SLB, J.B. Hunt Transport And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

Shares of Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) rose sharply in today's pre-market trading after the company announced a binding term sheet for a strategic <a href="https://www.benzinga.com/quote/VINC/news">merger with Oqory, Inc</a>.
Vincerx Pharma shares jumped 63.9% to $0.3180 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) gained 120% to $4.76 in pre-market trading after surging around 380% on Friday.</li>
<li>Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) gained 98.4% to $2.58 in pre-market trading after gaining 27% on Friday.</li>
<li>Energous Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) rose 78.7% to $0.7237 in pre-market trading.</li>
<li>Castellum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) gained 54.2% to $2.19 in pre-market trading after gaining 3% on Friday. Castellum announced the pricing of a previously announced stock offering of 4,355,000 shares at 85 cents per share for gross proceeds of approximately $3.7 million.</li>
<li>Solidion Technology Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) gained 51.2% to $1.06 in pre-market trading after surging around 69% on Friday.</li>
<li>Aeries Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) gained 41.4% to $1.24 in pre-market trading after falling around 5% on Friday.</li>
<li>KORE Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) rose 31.6% to $3.21 in pre-market trading after climbing around 28% on Friday.</li>
<li>Palladyne AI Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) gained 22.7% to $14.45 in pre-market trading after gaining over 61% on Friday.</li>
<li>Solid Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) gained 15% to $2.45 in pre-market trading after adding 9% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) fell 43.3% to $0.34 in pre-market trading as the company priced its $5 million public offering 16.13 million common shares at 31 cents per share.</li>
<li>Snow Lake Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) shares tumbled 33.1% to $1.07 in pre-market trading after surging around 82% on Friday.</li>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) declined 27.5% to $0.43 in pre-market trading after jumping around 267% on Friday.</li>
<li>Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares dipped 16.5% to $3.07 in pre-market trading. Citius Pharmaceuticals reported a net loss of $39.4 million, or $5.97 per share for the full year ended Sept. 30, versus a year-ago net loss of $32.5 million, or $5.57 per share.</li>
<li>Hudson Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) shares fell 15.5% to $11.31 in pre-market trading.</li>
<li>Tamboran Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBN#NYSE">TBN</a>) fell 14.4% to $16.00 in pre-market trading.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares fell 14.4% to $1.97 in pre-market trading after jumping 32% on Friday.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) fell 13.4% to $13.01 in today's pre-market trading.</li>
<li>HarborOne Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) dipped 11.5% to $10.60 in pre-market trading.</li>
<li>Sprott Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SII#NYSE">SII</a>) fell 6.4% to $39.31 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42700627/how-to-earn-500-a-month-from-rpm-international-stock-ahead-of-q2-earnings">How To Earn $500 A Month From RPM International Stock Ahead Of Q2 Earnings</a></li>
</ul>

Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.14 by 92.86 percent. This is a 80 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $114.615 million which beat the analyst consensus estimate of $108.946 million by 5.20 percent. This is a 3.07 percent increase over sales of $111.202 million the same period last year.

Natures Sunshine Products Q3 2024 Adj. EPS $0.27 Beats $0.14 Estimate, Sales $114.615M Beat $108.946M Estimate

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) raises FY2024 sales outlook from $436.00 million-445.00 million to $443.00 million-448.00 million.

Natures Sunshine Products Raises FY2024 Sales Guidance from $436.00M-445.00M to $443.00M-448.00M  VS Est. $439.16M

Canaccord Genuity analyst Susan Anderson initiated coverage on Nature&#8217;s Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/NATR/analyst-ratings" rel="noreferrer noopener">and a price forecast of&nbsp;$18.</a>
The analyst highlights that the company&#8217;s products are distributed in over 40 countries, with Asia leading at 45% of sales, North America at 31%, Europe at 18%, and LATAM and other regions at 8% as of FY23.
According to the analyst, Nature&#8217;s Sunshine is poised for margin expansion as it increases sales through three key strategies: investing in the higher-margin, rapidly growing digital sector, expanding its international presence in critical markets, and driving innovation in a sector with rising consumer interest.
Anderson writes these initiatives should allow the company to reach the 15% adjusted EBITDA margin goals by FY28, up from ~9% in FY23.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40859088/kkr-aims-to-replicate-european-private-equity-success-report" rel="noreferrer noopener">KKR Aims To Replicate European Private Equity Success: Report</a>
The analyst points out that, given the global shift towards greater health awareness post-pandemic, the company is well-positioned to capture a substantial share of the expanding market.
According to the analyst, the company&#8217;s gross margins could improve through greater product innovation, a shift towards higher-margin digital products, and relief from cost inflation and currency headwinds.
The analyst forecasts that if sales grow at a low-single-digit CAGR, management could enhance operating expenses by approximately 300 basis points.
Anderson projects FY24 adjusted EPS of $0.54, with net sales of $439.5 million.
Price Action: NATR shares are trading higher by 6.26% to $14.08 at last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40858884/wall-street-aims-for-fifth-straight-gain-small-caps-soar-as-2-ye" target="_blank" rel="noreferrer noopener">Wall Street Aims For Fifth Straight Gain, Small Caps Soar As 2-Year Yields Hit 2-Year Lows, Adobe Sinks: What&#8217;s Driving Markets Friday?</a></li>
</ul>

Analyst Color

Equities

Price Target

Initiation

Analyst Ratings

General

Nature's Sunshine To Gain From Margin Expansion - Analyst Projects 15% Adjusted EBITDA Margin By FY28

Comments

Natures Sunshine Products

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL